Tandem Diabetes Care (TNDM) Gross Profit Growth (1y) (2014 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Gross Profit Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | 15.59% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 21.17% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 13.68% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 17.10% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 12.38% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 13.54% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | 20.68% |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 20.50% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 8.95% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | 15.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.04% |
| Mar 31, 2026 | 15.52% |
| Dec 31, 2025 | 6.35% |
| Sep 30, 2025 | 7.73% |
| Jun 30, 2025 | 11.58% |
| Mar 31, 2025 | 25.07% |
| Dec 31, 2024 | 68.77% |
| Sep 30, 2024 | 38.88% |
| Jun 30, 2024 | 10.87% |
| Mar 31, 2024 | 14.19% |
| Dec 31, 2023 | -19.24% |
| Sep 30, 2023 | -14.05% |
| Jun 30, 2023 | -0.21% |
| Mar 31, 2023 | -8.99% |
| Dec 31, 2022 | 1.58% |
| Sep 30, 2022 | 7.94% |
| Jun 30, 2022 | 10.27% |
| Mar 31, 2022 | 24.30% |
| Dec 31, 2021 | 25.59% |
| Sep 30, 2021 | 48.13% |